调节帕金活动的酸的特异性和构造变化的机制
Dipti Ranjan Lenka1, Shradha Chaurasiya1, Loknath Ratnakar1
1Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Bhopal, Bhopal 462066, India.
Structure (London, England : 1993)
|October 5, 2024
概括
在PINK1和帕金基因突变导致帕金森病. 新的研究揭示了化无素和NEDD8如何激活帕金斯,澄清了疾病机制和特定突变.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 在PINK1和帕金的突变与早期发病的帕金森病有关.
- PINK1可化泛素 (Ub) 和NEDD8,激活帕金的E3结合酶.
- 基类蛋白 (pUbls) 的特异性和帕金激活的精确机制尚未完全理解.
研究的目的:
- 阐明pUb和化NEDD8 (pNEDD8) 激活Parkins的机制.
- 为了研究pUb/pNEDD8结合和随后的帕金的全激活的结构基础.
- 为了澄清与帕金森病相关的K211N突变对帕金森激活的影响.
主要方法:
- 进行X射线晶体学以确定与pUb/pNEDD8.8结合的帕金结构.
- 生物物理技术 (例如,表面等离子体共振) 来评估结合亲缘关系.
- 生物化学测试以测量E3结合酶活性.
主要成果:
- 与UB相比,NEDD8是一种更强大的帕金结合剂和激活剂.
- 结构和生物物理数据揭示了pUb/pNEDD8与帕金的RING1域和Ubl域与RING0域的特定结合相互作用.
- pUb/pNEDD8结合诱导了帕金催化RING2域中的全形状变化,导致激活.
- 在RING0中的K211N突变通过锁定RING2和RING0,独立于pUb/pNEDD8结合中断来抑制帕金活动.
结论:
- NEDD8在帕金激活中发挥着重要作用,可能比Ub.
- 了解这些激活机制,可以了解帕金森病的发病过程.
- K211N突变的抑制机制与之前的假设不同,突出了复杂的调节途径.
相关概念视频
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Phosphorylation
50.1K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.1K
The Proteasome
817
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
817
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K


